Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Addictovigilance contribution during COVID-19 epidemic and lockdown in France
Maryse Lapeyre‐Mestre, Alexandra Boucher, Amélie Daveluy, et al.
Therapies (2020) Vol. 75, Iss. 4, pp. 343-354
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Alcohol and other substance use during the COVID-19 pandemic: A systematic review
Amanda Roberts, Jim Rogers, Rachael Mason, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109150-109150
Open Access | Times Cited: 343
Overview of SARS-CoV-2 infection in adults living with HIV
Juan Ambrosioni, José Luís Blanco, Juliana Reyes‐Urueña, et al.
The Lancet HIV (2021) Vol. 8, Iss. 5, pp. e294-e305
Open Access | Times Cited: 180
Rapid realist review of the role of community pharmacy in the public health response to COVID-19
Ian Maidment, Emma Young, Maura MacPhee, et al.
BMJ Open (2021) Vol. 11, Iss. 6, pp. e050043-e050043
Open Access | Times Cited: 66
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework
Tribesty Nguyen, Jane A. Buxton
International Journal of Drug Policy (2021) Vol. 93, pp. 103236-103236
Open Access | Times Cited: 63
Benzodiazepine Misuse: An Epidemic Within a Pandemic
Ashish Sarangi, Terry McMahon, Jayasudha Gude
Cureus (2021)
Open Access | Times Cited: 59
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic
Wendy Wing-Yee Chong, Zeynep Ilgaz Acar, Meghan Lee West, et al.
Cannabis and Cannabinoid Research (2022) Vol. 7, Iss. 5, pp. 591-602
Open Access | Times Cited: 42
Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area
Yachar Dawudi, L. Azoyan, T. de Broucker, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3340-3346
Open Access | Times Cited: 10
Nitrous oxide: a unique official French addictovigilance national survey
Marylène Guerlais, Aurélie Aquizerate, Arthur Lionnet, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 17
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
Annagiulia Di Trana, Jérémy Carlier, Paolo Berretta, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 45
The Impact of the COVID-19 Pandemic on the Practice of Forensic Medicine: An Overview
Massimiliano Esposito, Monica Salerno, Edmondo Scoto, et al.
Healthcare (2022) Vol. 10, Iss. 2, pp. 319-319
Open Access | Times Cited: 24
Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication
Maria Gras, V. Gras-Champel, Julien Moragny, et al.
Annales Pharmaceutiques Françaises (2021) Vol. 79, Iss. 5, pp. 522-529
Open Access | Times Cited: 32
From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: more than 30 years of insight in medication diversion phenomenon in France
Maryse Lapeyre‐Mestre, Florence Fabre, Émilie Jouanjus
Therapies (2024)
Open Access | Times Cited: 4
Impact of COVID-19 Pandemic on Men Who Have Sex With Men That Practice Chemsex in France: Results From the National ERAS Web Survey
Perrine Roux, Cécile Donadille, Gabriel Girard, et al.
American Journal of Men s Health (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Mental Health and Psychological Wellbeing during the COVID-19 Lockdown: A Longitudinal Study in the Balearic Islands (Spain)
Joana Ripoll, Sara Contreras-Martos, Magdalena Esteva, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3191-3191
Open Access | Times Cited: 23
Neurological consequences of recreational nitrous oxide abuse during SARS-CoV-2 pandemic
Raphael Vollhardt, Julie Mazoyer, Lucy Bernardaud, et al.
Journal of Neurology (2021) Vol. 269, Iss. 4, pp. 1921-1926
Open Access | Times Cited: 20
Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020
Laurine Diaz, Céline Eiden, Émilie Jouanjus, et al.
Therapies (2023) Vol. 78, Iss. 6, pp. 647-657
Open Access | Times Cited: 7
An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study
Louise Carton, Axel Bastien, Nathalie Chérot‐Kornobis, et al.
Dialogues in Clinical Neuroscience (2023) Vol. 25, Iss. 1, pp. 101-111
Open Access | Times Cited: 7
Effect of COVID-19 on Mental Health Rehabilitation Centers
Alifiya Aamir, Sana Awan, Renato de Filippis, et al.
Journal of Psychosocial Rehabilitation and Mental Health (2020) Vol. 8, Iss. 1, pp. 97-100
Open Access | Times Cited: 20
Comparison of ARIMA, ES, GRNN and ARIMA–GRNN hybrid models to forecast the second wave of COVID-19 in India and the United States
Gang Wang, Tiantian Wu, Wudi Wei, et al.
Epidemiology and Infection (2021) Vol. 149
Open Access | Times Cited: 17
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
Thomas Soeiro, Clémence Lacroix, Vincent Pradel, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 16
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study
María José Niño-Orrego, Daniela Baracaldo-Santamaría, Claudia Patricia Ortíz, et al.
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 12
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey
Léna Blayac, Camille Ponté, Monique Lavaud, et al.
Therapies (2022) Vol. 78, Iss. 2, pp. 201-211
Open Access | Times Cited: 10
Changes in drug demand when a pandemic coincides with other outbreaks in a war zone country: a cross-sectional pilot study
Ebtesam A. Saleh, Randa N. Haddadin, Bassam Saleh, et al.
Journal of Pharmaceutical Policy and Practice (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system
Guido Mannaioni, Fabio Lugoboni
Drugs in Context (2023) Vol. 12, pp. 1-9
Open Access | Times Cited: 6
French Pharmacovigilance Public System and COVID-19 Pandemic
Aurélie Grandvuillemin, Milou‐Daniel Drici, A.‐P. Jonville‐Béra, et al.
Drug Safety (2020) Vol. 44, Iss. 4, pp. 405-408
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top